---

$5.87

-0.6850 ( -10.50% ) 182.9K

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-01-04	Sale	-178000.00	DeSilva Nishan M
2024-01-04	Sale	-548200.00	Miljkovic Milos
2024-01-04	Sale	-178000.00	SPRINGER TIMOTHY A
2023-11-15	Sale	-10328.00	BARABE TIMOTHY C
2023-11-15	Sale	-20000.00	Myers Scott Dunseth
2023-11-15	Sale	-6410.00	Sallin Aymeric
2023-11-15	Sale	-12820.00	ZENNER PATRICK J
2023-11-15	Sale	-2565.87	Miljkovic Milos
2023-11-15	Sale	-80000.00	DeSilva Nishan M
2023-11-15	Sale	-24785.08	SPRINGER TIMOTHY A